Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: Investor Clouseau who wrote (1709)	4/13/1999 1:38:00 PM
From: Mr. Fortune	Respond to of 108040

(BSNS WIRE) Steroidogenesis Inhibitors - STGI - to be Featured on Talk-S Steroidogenesis Inhibitors - STGI - to be Featured on Talk-Stock Web Site on April 15, 9:00 P.M. Health/Medical Writers LAS VEGAS--(BW HealthWire)--April 13, 1999--Steroidogenesis Inhibitors International (OTC BB:STGI) today announced that it will be a featured company on Talk-Stock Radio (http://www.talk-stock.com) with host Kenneth Coleman interviewing Dr. Alfred T. Sapse, President, and Dr. Janet Greeson, Executive Vice President on April 15, 1999 at 9:00 p.m. EDT (6:00 p.m. PDT) in the Talk-Stock Radio room. Talk-Stock.com is an on-line forum that broadcasts outstanding companies and investment opportunities to a worldwide audience with its broadcasts later translated into German, Spanish and Chinese. STGI is a pharmaceutical R&D Corporation, engaged in the development of anticortisol drugs to be used in diseases/conditions associated with elevated levels of the immunosuppressive hormone cortisol. STGI's flagship anticortisol drug, ANTICORT, has been approved by the FDA to be clinically tested in an HIV population -- a condition often associated with "high cortisol" that is apparently playing a major role in the destruction of the immune system as encountered in HIV+ and AIDS. This release may include "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable it can give no assurance that such expectations will prove correct. This is neither an offer to buy or sell a security. This release is for informational purposes only, from sources deemed to be reliable. For more information visit our World Wide Web page at www.anticort.com. --30--APS/CER/se* CONTACT: Steroidogenesis Janet Greeson, 702/735-7001 or Performance Strategies Richard L. Brown/Chuck Jordan, 303/471-5943 or H.L. Lanzet Inc. Herbert Lanzet/DeeDee Lanzet, 212/687-0061 KEYWORD: NEVADA INDUSTRY KEYWORD: INTERACTIVE/MULTIMEDIA/INTERNET MEDICINE PHARMACEUTICALS COMED COMPUTERS/ELECTRONICS Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com * end of story *